Float Short %

28.68

Margin Of Safety %

Put/Call OI Ratio

0.72

EPS Next Q Diff

-3.14

EPS Last/This Y

1.68

EPS This/Next Y

-0.31

Price

6.19

Target Price

15.29

Analyst Recom

2.14

Performance Q

-23.39

Relative Volume

0.88

Beta

2.78

Ticker: NVAX

22 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-04-14	NVAX	6.41	0.57	0.07	264064
2025-04-15	NVAX	6.39	0.56	0.25	267328
2025-04-16	NVAX	6.2	0.56	1.90	269234
2025-04-17	NVAX	6.01	0.61	2.19	287934
2025-04-18	NVAX	6	0.61	1.89	287934
2025-04-21	NVAX	6.02	0.88	0.07	238902
2025-04-22	NVAX	6.26	0.87	0.87	240882
2025-04-23	NVAX	7.47	0.87	0.17	246696
2025-04-24	NVAX	7.06	0.81	0.32	268900
2025-04-25	NVAX	6.67	0.79667037066434	1.4936419706084	271635
2025-04-28	NVAX	6.705	0.86139139299904	0.56421555127146	266568
2025-04-29	NVAX	6.42	0.85	0.23	276550
2025-04-30	NVAX	6.66	0.84	0.27	279831
2025-05-01	NVAX	6.4	0.83	0.73	282065
2025-05-02	NVAX	6.41	0.83	1.60	286610
2025-05-05	NVAX	6.27	0.85	0.46	273565
2025-05-06	NVAX	6.09	0.85	1.06	275999
2025-05-07	NVAX	5.94	0.85	0.51	283413
2025-05-08	NVAX	6.64	0.84	0.14	286992
2025-05-09	NVAX	5.97	0.74	0.33	311746
2025-05-12	NVAX	6.34	0.74	0.19	301219
2025-05-13	NVAX	6.18	0.72	0.21	306529
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

22 items 1 of 1

22 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-04-14	NVAX	6.41	151.8	-	0.27
2025-04-15	NVAX	6.39	151.8	-	0.27
2025-04-16	NVAX	6.21	151.8	-	0.27
2025-04-17	NVAX	6.00	151.8	-	0.27
2025-04-18	NVAX	6.00	151.8	-	0.49
2025-04-21	NVAX	6.01	151.8	-	0.49
2025-04-22	NVAX	6.25	151.8	-	0.49
2025-04-23	NVAX	7.47	151.8	-	0.49
2025-04-24	NVAX	7.05	151.8	-	0.49
2025-04-25	NVAX	6.67	151.8	-	0.49
2025-04-28	NVAX	6.70	151.8	-	0.49
2025-04-29	NVAX	6.42	151.8	-	0.49
2025-04-30	NVAX	6.67	151.8	-	0.49
2025-05-01	NVAX	6.41	151.8	-	0.49
2025-05-02	NVAX	6.41	151.8	-	0.49
2025-05-05	NVAX	6.27	151.8	-	0.49
2025-05-06	NVAX	6.09	234.0	-	0.49
2025-05-07	NVAX	5.95	234.0	-	0.49
2025-05-08	NVAX	6.65	234.0	-	0.49
2025-05-09	NVAX	5.97	-102.0	-	0.45
2025-05-12	NVAX	6.34	-102.0	-	0.45
2025-05-13	NVAX	6.19	-84.8	-	0.45
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

22 items 1 of 1

22 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-04-14	NVAX	-0.10	1.96	25.16
2025-04-15	NVAX	-0.10	1.96	25.16
2025-04-16	NVAX	-0.10	1.96	25.16
2025-04-17	NVAX	-0.10	1.96	25.16
2025-04-18	NVAX	-0.10	1.96	25.16
2025-04-21	NVAX	-0.10	1.68	25.16
2025-04-22	NVAX	-0.10	1.68	25.16
2025-04-23	NVAX	-0.10	1.68	25.16
2025-04-24	NVAX	-0.10	1.68	25.16
2025-04-25	NVAX	-0.10	1.68	25.16
2025-04-28	NVAX	-0.10	1.68	27.99
2025-04-29	NVAX	-0.10	1.68	27.99
2025-04-30	NVAX	-0.10	1.68	27.99
2025-05-01	NVAX	-0.10	1.68	27.99
2025-05-02	NVAX	-0.10	1.68	27.99
2025-05-05	NVAX	-0.10	1.13	27.99
2025-05-06	NVAX	-0.10	1.13	27.99
2025-05-07	NVAX	-0.10	1.13	27.80
2025-05-08	NVAX	-0.10	1.13	27.80
2025-05-09	NVAX	-0.10	1.13	27.80
2025-05-12	NVAX	-0.10	-0.65	28.68
2025-05-13	NVAX	-0.10	-0.65	28.68
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

22 items 1 of 1

Last Quarter Act. EPS

2.93

Avg. EPS Est. Current Quarter

0.08

Avg. EPS Est. Next Quarter

-0.21

Insider Transactions

-0.1

Institutional Transactions

-0.65

Beta

2.78

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

98.1

Max Drawdown 5-Year %

-98.8

Target Price

15.29

P/E

2.33

Forward P/E

16.43

PEG

0.06

P/S

0.8

P/B

P/Free Cash Flow

EPS

2.65

Average EPS Est. Cur. Y

0.45

EPS Next Y. (Est.)

0.14

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

38.14

Relative Volume

0.88

Return on Equity vs Sector %

-656.5

Return on Equity vs Industry %

-639.6

EPS 1 7Days Diff

EPS 1 30Days Diff

0.18

EBIT Estimation

Novavax, Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 952

Novavax, Inc., a biotechnology company, engages in the discovering, developing, and commercializing vaccines to protect against serious infectious diseases in the United States, Europe, and internationally. The company offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.

stock quote shares NVAX – Novavax, Inc. Stock Price stock today

news today NVAX – Novavax, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch NVAX – Novavax, Inc. yahoo finance google finance

stock history NVAX – Novavax, Inc. invest stock market

stock prices NVAX premarket after hours

ticker NVAX fair value insiders trading

Investment involves risk. As a general rule, you should only trade in financial products that you are familiar with and understand the risk associated with them. The risk warning described in each financial product below is not exhaustive, you should carefully consider your investment experience, financial situation, investment objective, risk tolerance level and consult your independent financial adviser as to the suitability of your situation prior making any investment.

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: NVAX

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Get Started

About

Last Quarter Act. EPS

Average EPS Est. Cur. Y